VEGFA and retinopathy of prematurity: Laser treatment combined with intravitreal anti-VEGF injection (Bevacizumab, Avastin, Roche Pharma AG, Grenzach-Wyhlen, Germany) was applied to three infants, 3.13% of all screened premature babies, and 15% of those with ROP, respectively.